Predicting Metabolic Dysfunction Associated Steatotic Liver Disease Risk Using Patient-Derived Induced Pluripotent Stem Cells.
Qin Y, Chhetri P, Theusch E, Lim G, Teker S, Kuang YL, Aziziraftar SK, Mehraban MH, Munoz-Howell A, Saxena V, Le Guillou D, Mattis AN, Maher JJ, Medina MW.
Qin Y, et al.
bioRxiv [Preprint]. 2025 Jan 15:2025.01.13.632567. doi: 10.1101/2025.01.13.632567.
bioRxiv. 2025.
PMID: 39868283
Free PMC article.
Preprint.